Search results for "vaccination"

showing 10 items of 660 documents

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

2022

6 páginas, 2 figuras, 3 tablas. Se puede acceder al texto completo de este artículo desde PubMedCentral: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490129 . Los datos de investigación utilizados en el mismo, se encuentran disponibles en: https://doi.org/10.1016/j.cmi.2021.09.031.

MaleMicrobiology (medical)medicine.medical_specialtyCOVID-19 VaccinesSARS-CoV-2-S antibodiesFingerstickSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Nursing home residentsCD8-Positive T-LymphocytesAntibodies ViralImmune systemComirnaty®COVID-19 vaccineInternal medicinemedicineHumansProspective StudiesProspective cohort studyAgedAged 80 and overVenipuncturebiologybusiness.industrySARS-CoV-2COVID-19General MedicineNursing HomesVaccinationInfectious Diseasesbiology.proteinFemaleOriginal ArticleAntibodybusinessCD8
researchProduct

Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant.

2015

Long pentraxin 3 (PTX3) is a non-redundant component of the humoral arm of innate immunity. The present study was designed to investigate the interaction of PTX3 with Neisseria meningitidis. PTX3 bound acapsular meningococcus, Neisseria-derived outer membrane vesicles (OMV) and 3 selected meningococcal antigens (GNA0667, GNA1030 and GNA2091). PTX3-recognized microbial moieties are conserved structures which fulfil essential microbial functions. Ptx3-deficient mice had a lower antibody response in vaccination protocols with OMV and co-administration of PTX3 increased the antibody response, particularly in Ptx3-deficient mice. Administration of PTX3 reduced the bacterial load in infant rats c…

MaleOvalbuminGene Expressionlcsh:MedicineMeningococcal VaccinesMeningococcal vaccineMeningitis MeningococcalNeisseria meningitidismedicine.disease_causeMicrobiologyMice03 medical and health sciencesImmune systemAdjuvants ImmunologicAntigenImmunitymedicineAnimalsRats Wistarlcsh:Science030304 developmental biologyMice KnockoutAntigens Bacterial0303 health sciencesNeisseria meningitidis PTX3 vaccination protocolsMultidisciplinarybiology030306 microbiologyNeisseria meningitidisVaccinationlcsh:RPTX3Antibodies BacterialVirologyBacterial LoadImmunity InnateImmunity HumoralRats3. Good healthSerum Amyloid P-ComponentC-Reactive ProteinAnimals Newbornbiology.proteinFemalelcsh:QAntibodyBacterial outer membraneResearch ArticlePLoS ONE
researchProduct

Vaccine hesitancy and refusal among parents: An international ID-IRI survey

2022

Introduction: Although vaccines are the safest and most effective means to prevent and control infectious diseases, the increasing rate of vaccine hesitancy and refusal (VHR) has become a worldwide concern. We aimed to find opinions of parents on vaccinating their children and contribute to available literature in order to support the fight against vaccine refusal by investigating the reasons for VHR on a global scale.Methodology: In this international cross-sectional multicenter study conducted by the Infectious Diseases International Research Initiative (ID-IRI), a questionnaire consisting of 20 questions was used to determine parents' attitudes towards vaccination of their children.Resul…

MaleParentsHealth Knowledge Attitudes PracticeAn international ID-IRI survey- JOURNAL OF INFECTION IN DEVELOPING COUNTRIES cilt.16 sa.6 ss.1081-1088 2022 [Cag Y. Al Madadha M. E. ANKARALI H. ÇAĞ Y. Onder K. D. Seremet-Keskin A. Kizilates F. Civljak R. Shehata G. ALAY H. et al. -Vaccine hesitancy and refusal among parents]VaccinationGeneral MedicinePatient Acceptance of Health CareMicrobiologyCommunicable DiseasesparentInfectious DiseasesCross-Sectional StudiesVirologySurveys and Questionnairesvaccine refusalHumansvaccine refusal.ParasitologyFemaleVaccination HesitancyChildVaccine hesitancy
researchProduct

Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy

2019

Influenza A and B outbreaks occur each year with different activity and molecular patterns. To date, knowledge of seasonal epidemiology remains a prerequisite not only to put in place the most effective immunization strategy against influenza but also to identify population groups at higher risk of developing serious complications. A retrospective analysis of influenza surveillance data from 2010 to 2018 aimed to explore the epidemiology of influenza in Sicily, at the primary care and hospital level. Overall, 6,740 patients with acute respiratory infection were tested, of which 3,032 (45.0%) were positive for influenza. The relative proportion of type A and B viruses markedly varied across …

MalePediatricsCommunityDiseaseSettore MED/42 - Igiene Generale E ApplicataSeverity of Illness IndexDisease Outbreakslaw.inventionRisk FactorslawEpidemiologyChildRespiratory Tract InfectionsSicilyeducation.field_of_studyVaccinationRespiratory infectionArticlesMiddle AgedIntensive care unitHospitalizationIntensive Care UnitsInfectious DiseasesMolecular surveillanceInfluenza A virusChild PreschoolEpidemiological MonitoringFemaleSeasonsAdultmedicine.medical_specialtyAdolescentPopulationYoung AdultVirologyInfluenza HumanmedicineHumanseducationAgedRetrospective Studiesbusiness.industryInfantOutbreakmedicine.diseaseObesityInfluenzaInfluenza B virusImmunizationParasitologyRisk factorbusinessThe American Journal of Tropical Medicine and Hygiene
researchProduct

Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in …

2017

The ESCULAPIO Project aims at increasing awareness on vaccine preventable infectious diseases (VPID) and vaccinations in different target populations and to spread the culture of prevention. Information/training interventions on VPID have been developed and health promotion activities for the general population, students and their parents, teachers and health care workers (HCWs) were set up. In Tuscany, educational courses on VPID in high schools were organized and students were stimulated to prepare informative materials on VPID for lower grade school pupils. In Liguria, an educational card game (named 'Vaccine at the Fair') was presented to children of primary schools. Stands in shopping …

MalePediatricsVaccination schedulePsychological interventionSettore MED/42 - Igiene Generale E Applicataawareness; communication; general population; health care workers; infectious diseases; students; vaccination coverage; vaccineinfectious diseasesgeneral population0302 clinical medicinevaccineHealth careImmunology and Allergyawareness030212 general & internal medicineeducation.field_of_studyVaccinesvaccination coverageSchoolsstudentscommunicationVaccinationResearch PapersVaccinationItalyOrder (business)Femalemedicine.medical_specialtystudentAdolescentinfectious disease030231 tropical medicineImmunologyPopulationeducationawarenehealth care workers03 medical and health sciencesYoung AdultmedicineDisease Transmission InfectiousHumanseducationHealth communicationPharmacologybusiness.industryHealth promotionHealth Communicationhealth care workerFamily medicinebusinessHuman vaccinesimmunotherapeutics
researchProduct

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a mu…

2015

Equipe CHU UB (EA) Pôle MERS CT3 Hors Enjeu ANRS HB04 B-BOOST study group : Hugues Aumaitre (Centre Hospitalier Marechal Joff re, Perpignan, France); Jean-Luc Berger (Centre Hospitalier Universitaire de Reims– Hopital Robert Debre, Reims, France); Alain Devidas (Hopital Gilles de Corbeil–Centre Hospitalier Sud Francilien, Corbeil Essonne, France); Sophie Abgrall (Centre Hospitalier Universitaire Avicenne, Avicenne, France); Olivier Patey (Centre Hospitalier Intercommunal de Villeneuve St Georges, Villeneuve Saint Georges, France); Marie-Christine Drobacheff Thiebaut (Centre Hospitalier Universitaire de Besancon–Hopital Saint Jacques, Besancon, France); Frederic Lucht (Centre Hospitalier Uni…

MalePediatricsefficacyHIV InfectionsBooster doselaw.invention0302 clinical medicineRandomized controlled triallaw[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesvaccineSingle-Blind Method030212 general & internal medicineVaccines Synthetic0303 health sciencesnumberinfected patientMiddle AgedHepatitis BHepatitis B3. Good healthVaccinationTreatment OutcomeInfectious Diseaseshomosexual man[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesFemaleFranceViral hepatitisAdultmedicine.medical_specialtyHepatitis B vaccineImmunization SecondaryvirusYoung Adult03 medical and health sciencesmedicineHumansHepatitis B VaccinesHepatitis B AntibodiesAgedIntention-to-treat analysis030306 microbiologybusiness.industrymedicine.diseaserateRegimeninjection[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessimpaired response
researchProduct

Changes in quality of life in individuals with narcolepsy type 1 after the H1N1-influenza epidemic and vaccination campaign in Norway: a two-year pro…

2018

Abstract Objective Cross-sectional studies show a lower health-related quality of life (HRQoL) in individuals with narcolepsy. We aimed to describe changes in HRQoL after two years of multidisciplinary follow-up in a cohort of mainly post-H1N1 vaccination narcolepsy type-1 (NT1) patients in Norway. Methods Prospective-cohort study. Narcolepsy diagnosis was based on the International Classification of Sleep Disorders (third edition). Psychiatric comorbidity was assessed using the Achenbach System of Empirically Based Assessment (ASEBA). HRQoL was evaluated with the Pediatric Quality of Life Inventory (PedsQL™ Generic Core Scales 4.0) at baseline and follow-up. Mean follow-up time was 20.7 (2…

MalePediatricsmedicine.medical_specialtyAdolescentComorbiditySeverity of Illness IndexYoung Adult03 medical and health sciencesInfluenza A Virus H1N1 Subtype0302 clinical medicineQuality of lifeInfluenza HumanmedicineHumansInternational Classification of Sleep DisordersProspective Studies030212 general & internal medicineChildProspective cohort studyNarcolepsyImmunization ProgramsNorwaybusiness.industryVaccinationGeneral Medicinemedicine.diseasehumanitiesPeer reviewVaccinationCross-Sectional StudiesTest scoreCohortQuality of LifeFemaleSodium Oxybatebusiness030217 neurology & neurosurgeryAdjuvants AnesthesiaNarcolepsySleep Medicine
researchProduct

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-co…

2005

Objective The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with five doses of acellular pertussis–containing vaccine. Study design Adolescents (n = 319) previously vaccinated with either 5 doses of diphtheria–tetanus–acellular pertussis (DTaP) (n = 193) or 4 doses of DTaP plus another acellular pertussis–containing vaccine received one dose each of Tdap and hepatitis A vaccine in a double-blinded, randomized, crossover trial. Rates of adverse events (AEs) after vaccination with Tdap versus hepatitis A and rates of local AEs among adolescents vaccinated with Tdap (sixth acellular…

MalePediatricsmedicine.medical_specialtyAdolescentWhooping CoughHepatitis A vaccineBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinescomplex mixturesSeverity of Illness IndexDouble-Blind MethodGermanymedicineHumansProspective StudiesAdverse effectChildWhooping coughImmunization ScheduleAntigens BacterialCross-Over StudiesTetanusDose-Response Relationship Drugbusiness.industryTetanusDiphtheriaIncidenceVaccinationHepatitis ADiphtheriamedicine.diseaseSurgeryVaccinationTreatment OutcomePediatrics Perinatology and Child HealthFemalebusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

Can SARS‐CoV‐2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review

2021

Abstract Introduction Although the COVID‐19 vaccination is deemed safe, exact incidence and nature if adverse effects, particularly dermatological ones, are still unknown. Objective To describe the demographic, clinical, morphological characteristics, outcomes, and timing of development of herpes zoster to the various COVID‐19 vaccines. And to identify on whether COVID‐19 vaccine has temporal relationship between development of herpes zoster (HZ). Methods We have performed a systemic review of articles from PubMed and Embase using MeSH and keywords like “Shingles,” “Herpes zoster,” “Varicella zoster,” “COVID‐19,” “Vaccine,” “SARS‐CoV‐2.” No filters including country of publication, language…

MalePediatricsmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)herpes zosterReview ArticleDermatologyMalignancyCovidVaricella zosterChickenpoxCOVID‐19vaccinemedicineHerpes Zoster VaccineHumansAdverse effectSARS-CoV-2business.industryIncidence (epidemiology)Metabolic disorderCOVID-19Middle Agedmedicine.diseaseVaccinationFemalebusinessShinglesJournal of Cosmetic Dermatology
researchProduct

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according t…

2012

CONTEXT: In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB) remains a major cause of invasive disease in early childhood in developed countries. OBJECTIVE: To determine the immunogenicity and reactogenicity of a multicomponent MenB vaccine (4CMenB) and routine infant vaccines when given either concomitantly or separately. DESIGN, SETTING, AND PARTICIPANTS: Phase 2b, multicenter, open-label, parallel-group, randomized controlled study of 1885 infants enrolled at age 2 months from August 2008 to July 2010 in Europe. INTERVENTION: Participants were randomized 2:2:1:1 to receive (1) 4CMenB at 2, 4, and 6 months with routine vaccines (7-valent pneumococcal and comb…

MalePediatricsmedicine.medical_specialtyContext (language use)Meningococcal VaccinesMeningococcal vaccineNeisseria meningitidisSerum Bactericidal Antibody AssayDrug Administration SchedulemedicineHumansImmunization ScheduleVaccinesVaccines SyntheticReactogenicityTetanusbusiness.industryDiphtheriaInfantGeneral Medicinemedicine.diseasePoliomyelitisVaccinationMeningococcal InfectionsAntibody FormationFemalePertactinbusiness
researchProduct